A novel organotellurium compound (RT-01) as a new antileishmanial agent

34Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

Abstract

Leishmaniasis is a neglected disease and endemic in developing countries. A lack of adequate and definitive chemotherapeutic agents to fight against this infection has led to the investigation of numerous compounds. The aim of this study was to investigate the effect of RT-01, an organotellurane compound presenting biological activities, in 2 experimental systems against Leishmania amazonensis. The in vitro system consisted of promastigotes and amastigotes forms of the parasite, and the in vivo system consisted of L. amazonensis infected BALB/c mice, an extremely susceptible mouse strain. The compound proved to be toxic against promastigotes and amastigotes. The study also showed that treatment with RT-01 produces an effect similar to that treatment with the reference antimonial drug, Glucantime, in L. amazonensis infected mice. The best results were obtained following RT-01 intralesional administration (720 μg/kg/day); mice showed significant delay in the development of cutaneous lesions and decreased numbers of parasites obtained from the lesions. Significant differences in tissue pathology consisted mainly of no expressive accumulation of inflammatory cells and well-preserved structures in the skin tissue of RT-01-treated mice compared with expressive infiltration of infected cells replacing the skin tissue in lesions of untreated mice. These findings highlight the fact that the apparent potency of organotellurane compounds, together with their relatively simple structure, may represent a new avenue for the development of novel drugs to combat parasitic diseases.

References Powered by Scopus

Leishmaniasis: Current situation and new perspectives

1857Citations
N/AReaders
Get full text

Organoselenium and organotellurium compounds: Toxicology and pharmacology

1798Citations
N/AReaders
Get full text

Advances in leishmaniasis

1463Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Recent developments in drug discovery for leishmaniasis and human african trypanosomiasis

297Citations
N/AReaders
Get full text

Therapeutic potential of selenium and tellurium compounds: Opportunities yet unrealised

177Citations
N/AReaders
Get full text

Metal Compounds against Neglected Tropical Diseases

140Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Cantalupo Lima, C. B., Arrais-Silva, W. W., Rodrigues Cunha, R. L. O., & Giorgio, S. (2009). A novel organotellurium compound (RT-01) as a new antileishmanial agent. Korean Journal of Parasitology, 47(3), 213–218. https://doi.org/10.3347/kjp.2009.47.3.213

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 14

54%

Professor / Associate Prof. 7

27%

Lecturer / Post doc 3

12%

Researcher 2

8%

Readers' Discipline

Tooltip

Chemistry 10

42%

Agricultural and Biological Sciences 7

29%

Immunology and Microbiology 4

17%

Medicine and Dentistry 3

13%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 17

Save time finding and organizing research with Mendeley

Sign up for free